Germany· DE-A57-f0304eafd4816ba1

Exemestan Accord

A exemestane product containing exemestane, registered in Germany by Accord Healthcare B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L02BG06

Checked against EMA Article 57 (European Union) on September 30, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about exemestaneAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Exemestane is registered in 17 of 19 countries.

Countries holding a registration under ATC L02BG06 (exemestane), each read from that country’s own register.

This record: Germany, from EMA Article 57 (European Union)
10 of them publish a price we can compare per daily dose

Search exemestane products by name

Exemestane · ATC L02BG06

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of exemestane costs, country by country.

Normalised to the WHO defined daily dose (25 mg), the median price runs from $1.43 in France to $3.32 in Switzerland — a ×2.3 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Exemestane · price per daily dose (25 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.32
IT Italy$2.46
FR France$1.43

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)

Active substance: Exemestane
Manufacturer: Accord Healthcare B.V.
Country: Germany (DE)
ATC code: L02BG06
ATC class: Exemestane
Defined daily dose: 25 mg, O
Reimbursed: Not published by this register
Source register: EMA Article 57 (European Union)
Last checked: September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

236 interactions on record for exemestane.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check exemestane against other medicines How interaction checks work

Exemestane · interactions on record

236 records

1 severe
83 moderate
152 info

Most severe, free to view

ThalidomideL04AX02severe
TroglitazoneA10BG01moderate
SulfinpyrazonB01AC12moderate
FostamatinibB02BX09moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Exemestane in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All exemestane products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Aromasin, Exemestan Accord
Belgium · Aromasin, Exemestan Sandoz
Bulgaria · Аромазин, Екземегратис
Cyprus · Exedral
Czechia · Aromasin, Astexana
Denmark · Aromasin, Exemestan Accord
Estonia · Aromasin, Exemestane Accord
Spain · Aromasil, Exemestano Aurovitas
Finland · Aromasin, Exemestan Pfizer
France · Aromasine, Exemestane Accord
United Kingdom (Northern Ireland) · Aromasin, Exemestane
Greece · Aromaplex, Aromasin
Croatia · Aromasin, Eksemestan Jgl
Hungary · Aromasin, Exemestane Pharmacenter
Ireland · Aromasin, Exemestane Accord
Iceland · Aromasin, Exemestan Actavis
Italy · Aromasin, Axelta
Lithuania · Aromasin, Exemestane Accord
Luxembourg · Aromasin, Exemestan Ratiopharm
Latvia · Exemestane Accord, Exemestane Sanoswiss
Malta · Aromasin, Exedral 25
Netherlands · Aromasin, Exemestaan Accord
Norway · Aromasin, Exemestan Sandoz
Poland · Astexana, Glandex
Portugal · Aromasin, Exemestano Accord
Romania · Aromasin, Exemestan Accord
Sweden · Exemestan Actavis, Exemestan Sandoz
Slovenia · Aromasin
Slovakia · Aromasin, Astexana

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cd8533f4-2e91-4682-8269-1d1a00a6ae56
GET /v1/drugs/cd8533f4-2e91-4682-8269-1d1a00a6ae56?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Exemestane",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

API reference MCP server Plans

See everything about exemestane.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console